Quanyin Hu, Ph.D.
Pharmaceutical Sciences Division
School of Pharmacy
UW Carbone Cancer Center
School of Medicine and Public Health
University of Wisconsin-Madison
Prof. Hu received his Ph.D. degree in Biomedical Engineering from the University of North Carolina at Chapel Hill and North Carolina State University under the supervision of Prof. Zhen Gu in 2018. From 2018-2020, he was a postdoc associate in the laboratory of Prof. Robert Langer in Koch Institute for Integrative Cancer Research at MIT. Prof. Hu joined UW-Madison in 2020 as an assistant professor in the Pharmaceutical Sciences Division at the School of Pharmacy.
Welcome to Hu CIPT lab at UW-Madison! The ultimate goal of our laboratory is to leverage the delivery approach to address current clinical challenges and facilitate translational research by combining cell therapy, immunotherapy, and personalized therapy. Specifically, by adopting the concept of “CIPT”, we are getting inspiration from natural cells to design our delivery tools and particularly interested in engineering cells and cell derivatives as vehicles for delivery of small/macromolecules, proteins, and antibodies to treat a broad array of diseases, including cancer, infectious disease, and autoimmune disease. We are also leveraging the interaction between synthetic materials and immune cells to modulate the immune response in a controllable fashion. To advance personalized therapy, neoantigen-based vaccination and microbiota research will be emphasized in our lab to transform traditional “one-size-fits-all” treatment to precision medicine for each individual.
Feb. 2021: Our very first review paper has been accepted for publication in Advanced Functional Materials!
Dec. 2020: Dr. Hu has been invited to serve as an Associated Editor for Journal of Nanobiotechnology (IF=6.5)!
Oct. 2020: Dr. Liu and Tina joined CIPT lab!
July 2020: Hu CIPT lab officially opens!!!